RFK Jr. forces FDA to reconsider 12 unproven peptides after 2023 ban

The Food and Drug Administration on Wednesday announced meeting dates for advisors to discuss lifting restrictions on 12 unproven peptides that the agency deemed to pose significant safety risks in 2023.

FDA will consider easing restrictions on peptides as RFK Jr. calls himself a "big fan"

The FDA meeting announcement​ follows repeated pledges by Health Secretary Robert F. Kennedy Jr. to loosen regulations on peptides, which are often pitched as a quick way to build muscle, heal injuries or appear younger.

Millions Take Xanax. A New FDA Recall Could Affect Prescriptions

A widely prescribed anxiety medication is being pulled from shelves nationwide after a quality issue triggered a recall from the U.S. Food and Drug Administration. The FDA announced that a specific lot of extended-release Xanax—one of the most commonly used medications to treat anxiety and panic disorders—failed to meet required manufacturing standards,

Women can't get estrogen patches. Here's what the FDA is doing to help.

Estrogen patches, one of the most popular menopause treatments, have been in short supply this year. Now the FDA is working to fix it.

Warning issued as Xanax recalled nationwide, FDA announces

The FDA has designated it a class II recall.

FDA issues nationwide recall for Xanax: Second-highest risk level

Viatris Specialty LLC initiated a nationwide retail-level recall of Xanax XR extended-release tablets, the company said in a notice to California’s Board of Pharmacy. The FDA classified the recall as a Class II — second-highest risk level — meaning the product may cause temporary or medically reversible health effects,

FDA recalls 3.1M bottles of eye drops sold at CVS, Walgreens, more. Here’s why

The U.S. Food and Drug Administration recalled more than 3.1 million bottles of eye drops sold at CVS, Walgreens and other drug stores. Here's why

Vitamin recall update as FDA sets risk level

Certain people "run the risk of a serious or life-threatening allergic reaction if they consume this product," the firm warned.

FDA seeks added safety data from Lilly on newly approved weight-loss pill

The FDA also asked Lilly to conduct a milk-only lactation study in women who have received a dose to assess concentrations of the drug in breast milk.

Ophthalmologist is front-runner for next FDA vaccine chief, sources say

Dr. Houman Hemmati, an ophthalmologist critical of the government’s Covid vaccine response, is the front-runner for the role of the FDA's vaccine chief, sources say.

Woburn biotech to lay off more than 200 after second FDA rejection of skin cancer treatment

In a notification the state received from Replimune on Monday, the Woburn-based company said it was laying off 63 employees, with the job cuts taking place from April 13 through April 24. That’s about 13 percent of the nearly 480 employees the company last reported in March 2025.

FDA recalls 300,000 Teva blood pressure patches over unapproved ingredient

The Class II recall covers 3 dosages of clonidine transdermal patches made by Actavis Laboratories, with no adverse health consequences expected